Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9909)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 24, 2019 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maurya N, Singh R, Goel A, Singhai A, Singh UP, Agrawal V, Garg M. Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients. World J Clin Oncol 2019; 10(4): 166-182 [PMID: 31114749 DOI: 10.5306/wjco.v10.i4.166] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v10/i4/166.htm |
| Number | Citing Articles |
| 1 |
María Victoria Mencucci, Lara Lapyckyj, Marina Rosso, María José Besso, Denise Belgorosky, Mariana Isola, Silvia Vanzulli, Catalina Lodillinsky, Ana María Eiján, Juan Carlos Tejerizo, Matías Ignacio Gonzalez, María Ercilia Zubieta, Mónica Hebe Vazquez-Levin. Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00283
|
| 2 |
Lichao Zhang. Efficacy and safety of Solifenacin combined with Mirabegron in treating overactive bladder in female patients following bladder instillation for bladder cancer. American Journal of Translational Research 2025; 17(2): 1144 doi: 10.62347/BXQN5596
|
| 3 |
R. Singh, U. P. Singh, V. Agrawal, M. Garg. Retraction Note: Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10450-1
|